Article
Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).
Blood - 2 Jul 2020
Brown Anna L, Hahn Christopher N, Scott Hamish S
Abstract excerpt
Recognition that germline mutations can predispose individuals to blood cancers, often presenting as secondary leukemias, has largely been driven in the last 20 years by studies of families with inherited mutations in the myeloid transcription factors (TFs) RUNX1, GATA2, and CEBPA. As a result, in 2016, classification of myeloid neoplasms with germline predisposition for each of these and other genes was added to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
